LogicBio Therapeutics, Inc. Operating Lease Liability
LogicBio Therapeutics, Inc. had Operating Lease Liability of $4.05 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2022-11-14
- 2022-09-30: Operating Lease, Liability $4.05M.
- 2022-06-30: Operating Lease, Liability $4.36M.
- 2022-03-31: Operating Lease, Liability $4.66M.
- 2021-12-31: Operating Lease, Liability $4.95M.
| Period end | Operating Lease, Liability |
|---|---|
| 2022-09-30 | $4.05M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $4.36M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $4.66M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $4.95M 10-Q · filed 2022-11-14 |
| 2021-09-30 | $5.24M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $5.52M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $5.79M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $6.05M 10-Q · filed 2021-11-15 |
| 2020-09-30 | $6.33M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $6.67M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $199.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $504.00K 10-Q · filed 2020-11-09 |
| 2019-09-30 | $669.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $967.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $1.26M 10-Q · filed 2019-05-14 |